Question of the Week

Question :
Posted On : 07 Mar 2009
Current concepts on management of Hepatic Encephalopathy
4
Expert Answer :
No expert answer available.
Answer Discussion :
S
SANTOSH POLISHETTY
Profile
reduction of production and absprption of ammonai, increased metabolism of ammonia in the tissues,reduction of false neurotransmitters,inhibition of aminobutyric acid and benzodiazepine receptors,correction of manganeese deposition in the basal ganglia,orthotopic liver transplantation
16 years ago
V
vetri vela
Profile
Iv fluids, Lactulose, Neomycin, Sodium Benzoate,
16 years ago
R
Ramana Chilukuri
Profile
lactulose gut sterilisation with metronidazole dialysis
16 years ago
P
pediatriconcall
Profile
Most current therapies are designed to treat the hyperammonemia that is a hallmark of most cases of hepatic encephalopathy. Protein restricted diet with rich in branched-chain amino acids. However avoid PEM state. Lactulose and neomycin are still recommended. Rifaximin, a nonabsorbable derivative of rifampin been used in the treatment of hepatic encephalopathy. A number of concerns remain regarding rifaximin`s role in the treatment of hepatic encephalopathy. It remains to be determined if rifaximin can improve severe encephalopathy symptoms as rapidly as lactulose. L-ornithine L-aspartate {LOLA} can increase ammonia clearance. Their administration results increased glutamate levels. Ammonia is subsequently used in the conversion of glutamate to glutamine by glutamine synthetase. LOLA was found to be effective in treating hepatic encephalopathy in a number of European trials. Zinc deficiency is common in cirrhosis. Even in patients who are not zinc deficient, zinc administration has the potential to improve hyperammonemia by increasing the activity of ornithine transcarbamylase, an enzyme in the urea cycle. The subsequent increase in ureagenesis results in the loss of ammonia ions. Sodium benzoate, sodium phenylbutyrate, sodium phenylacetate can be used to treat severe hyperammonemia. L-carnitine improved hepatic encephalopathy symptoms in several small studies of patients with cirrhosis.30 Whether the medication works by improving blood ammonia levels or whether it works centrally perhaps by decreasing brain ammonia uptake remains unclear.
16 years ago




Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0